Danone generates revenue through three distinct business segments that collectively produced $29.8 billion in FY2024 sales. The Essential Dairy and Plant-Based (EDP) segment contributed $14.7 billion, representing 49.2% of total revenue, with recurring operating income of $1.2 billion at an 8.5% margin. This segment encompasses yogurts—both classic and drinkable—including functional subcategories such as immunity, gut health, and high-protein variants; coffee creations including creamers and ready-to-drink beverages; desserts; and plant-based alternatives spanning beverages, yogurt alternatives, cheese, ice cream, and frozen desserts. More than 60% of EDP revenues derive from value-added and functional segments rather than commodity dairy, providing a margin buffer against raw milk price volatility. The segment's geographic distribution shows Europe contributing $4.7 billion (32% of EDP), North America $6.5 billion (44%), China/North Asia/Oceania $405.5 million (3%), and the remaining regions $3.1 billion (21%). North American EDP growth of 5.4% like-for-like in FY2024 was driven by high-protein yogurt platforms growing double-digit, coffee creations momentum, and the Silk and So Delicious plant-based brands acquired through the 2016 WhiteWave transaction. European EDP grew 0.9% like-for-like, reflecting mature market dynamics and intense private-label competition, while China/North Asia/Oceania EDP surged 11.6% like-for-like on strong Japanese performance. The EDP segment's margin of 8.5% is the lowest among the three divisions, reflecting the commodity nature of base dairy and the competitive intensity of retail yogurt markets. The Specialized Nutrition segment generated $9.7 billion in FY2024 revenue (32.6% of total) with $2.0 billion in recurring operating income at a 20.6% margin—the highest-margin segment and the company's primary profit engine. This division covers infant milk formula and complementary feeding for babies, plus medical nutrition for children and adults with conditions including allergies, metabolic disorders, cancer, stroke, and malnutrition. Danone holds the #2 global position in early life nutrition and the #4 position in adult medical nutrition. The segment's profitability stems from regulatory barriers to entry, prescription-channel access, and brand trust built on decades of clinical research. China dominates this segment geographically, contributing $2.8 billion (29% of Specialized Nutrition sales), where Danone's Aptamil brand gained market share in an improving infant formula category. Europe contributed $3.4 billion (35%), while the Rest of World regions—including Indonesia, Thailand, Malaysia, UAE, Turkey, and Africa—generated $3.1 billion (32%). The medical nutrition sub-segment, while smaller than infant formula, generates higher margins due to prescription requirements and insurance reimbursement in many markets. Danone's Nutricia brand leads in tube feeding and disease-specific nutrition in Europe, with products like Nutrison for hospital use and Fortimel for home care. The Waters segment produced $5.4 billion (18.2% of total revenue) with $625.7 million in recurring operating income at an 11.5% margin, up 142 basis points from 10.1% in FY2023. This segment includes plain water, flavored water, and functional beverages under brands including Evian, Volvic, Badoit, Aqua, Mizone, and Bonafont. Europe contributed $2.3 billion (42% of Waters), while China/North Asia/Oceania added $832.8 million (15%) led by Mizone double-digit growth. The segment benefits from a portfolio balanced between safe tap-water markets—where premium brand expansion across occasions and channels is the priority—and non-safe tap-water markets where Danone leverages direct distribution access to deliver healthy hydration. In Indonesia, Danone's Aqua brand commands 70%+ market share in a country where tap water is not potable for most of the population. In Mexico, Bonafont is a leading bottled water brand. In China, Mizone functional water competes against energy drinks and sports beverages by offering vitamin-enhanced hydration. The waters segment's margin improvement in FY2024 reflects pricing power in premium segments (Evian, Volvic) and cost discipline in mass-market brands (Aqua, Bonafont). Danone's revenue model depends on brand equity that commands price premiums: in 2024, 87.7% of product volumes sold scored 3.5 stars or higher on the Health Star Rating system, enabling pricing power in functional categories. The company sells through multiple channels including retail supermarkets, convenience stores, pharmacies, hospitals, e-commerce platforms, and foodservice operators. Channel mix varies by segment: EDP is predominantly retail (75%), with foodservice and convenience contributing 15% and e-commerce 10%. Specialized Nutrition is split between retail (40%), pharmacy/hospital (35%), and e-commerce (25%). Waters is predominantly retail (80%), with foodservice and e-commerce contributing 10% each. In 2024, Danone's top ten customers worldwide accounted for approximately 20% of consolidated sales, with the top five representing approximately 14%, indicating moderate customer concentration risk. The largest customers are European retail chains (Carrefour, Tesco, Ahold Delhaize) and North American distributors (Walmart, Costco, Kroger). The United States remained the largest single country at 21% of sales ($6.3 billion), followed by China at 11% ($3.3 billion), France at 8% ($2.4 billion), Indonesia at 6% ($1.8 billion), and the United Kingdom at 6% ($1.8 billion). Revenue recognition follows standard FMCG patterns: product sales are recognized at the point of delivery to distributors or retailers, with trade promotions and discounts recorded as reductions to revenue. Danone's trade spending—promotions, discounts, and slotting fees—typically ranges from 15-20% of gross revenue, varying by market and channel. The company's working capital cycle benefits from strong cash conversion: in FY2024, cash flow from operating activities reached $4.2 billion before working capital changes, with working capital contributing $582.1 million positively, yielding total operating cash flow of $4.2 billion and free cash flow of $3.3 billion after $1006.1 million in capital expenditure. This cash generation funds a dividend policy that paid $1.5 billion to shareholders in 2024 ($2.3 per share, up 2.4%), while maintaining net debt at manageable levels. Danone's capital structure includes bonds with maturities extending to 2034, with the company maintaining investment-grade ratings from S&P, Moody's, and Fitch. The weighted average cost of debt was approximately 2.8% in FY2024, reflecting the company's strong credit profile and the low-interest-rate environment of recent years. The business model's vulnerability lies in its exposure to agricultural commodity prices: a 5% increase in liquid milk, milk powder, and other milk-based ingredients would increase costs by $167.9 million annually, while a 5% increase in plastics including PET would add $70.9 million. These sensitivities make productivity gains and pricing strategy critical to margin maintenance. The company addresses this through what it calls 'record productivity levels' in 2024, which contributed +242 basis points to margin improvement, partially offset by -173 basis points of reinvestment in advertising, promotion, product superiority, and capabilities. Danone's capital allocation framework prioritizes four uses: organic growth investment (R&D, marketing, capacity expansion), M&A in health-science categories, shareholder returns (dividends with potential buybacks), and debt reduction. In FY2024, the company allocated approximately 45% of free cash flow to dividends, 30% to debt reduction, 15% to capital expenditure, and 10% to share-based compensation and other. The dividend payout ratio of approximately 57% of recurring net income is conservative relative to European peers, reflecting management's desire to preserve balance sheet flexibility for acquisitions.